Congressional Affairs
How Can Something So Small Kill
Intro to FRS:
Fentanyl-Related Substances (FRS) are a deadly cocktail of synthetic drugs, laced with potentially fatal doses of fentanyl. Whether in pill or powder, even the tiniest amount of FRS is deadly.
Fentanyl-related substances are controlled in schedule I of the CSA. Public Law 118-158 extended schedule I status of fentanyl-related substances to March 31, 2025. On December 30, 2024 (89 FR 106384), a notice of proposed rulemaking was published for seven fentanyl-related substances, proposing the permanent placement of these substances under the CSA.
|
| 
|
Xylazine
Forensics on the Frontlines
* 2 mg of fentanyl equates to a potentially deadly dose
DEA Fentanyl Seizures in 2025
In 2024, DEA seized more than 60 million fentanyl-laced fake pills and nearly 8,000 pounds of fentanyl powder. The 2024 seizures are equivalent to more than 377 million lethal doses of fentanyl.
The 2025 fentanyl seizures represent over 81 million deadly doses. *
The 2025 fentanyl seizures represent over 81 million deadly doses. *
Millions of Fentanyl Pills Seized
+ 13,500,000
Pounds of Fentanyl Powder Seized
+ lbs. 588
* 2 mg of fentanyl equates to a potentially deadly dose
Statements for the Record
February 1, 2023 - Statement of Associate Administrator Jon DeLena - Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities
February 15, 2023 - Statement of Administrator Anne Milgram - Countering Illicit Fentanyl Trafficking
April 27, 2023 - Statement of Administrator Anne Milgram - Fiscal Year 2024 Request for the Drug Enforcement Administration
May 10, 2023 - Statement of Administrator Anne Milgram - A Review of the President’s Fiscal Year 2024 Funding Requests for the Federal Bureau of Investigation and for the U.S. Drug Enforcement Administration
June 21, 2023 - Statement of Matthew J. Strait Deputy Assistant Administrator Diversion Control Division - Responding to America's Overdose Crisis: An Examination of Legislation to Build Upon the SUPPORT Act
July 12, 2023 - Statement of Kemp L. Chester Senior Advisor, Office of National Drug Control Policy Committee on Homeland Security - Leading the Strategic Response to Disrupt the Flow of Illicit Fentanyl Across Our Borders
July 27, 2023 - Statement of Administrator Anne Milgram - Drug Enforcement Administration Oversight
October 24, 2023 - Statement of William F. Kimbell Chief of Operations Drug Enforcement Administration - Hearing Entitled, “TBD”
March 20, 2024 - Testimony of James Dunlap Deputy Under Secretary for Analysis Office of Intelligence and Analysis U.S. Department of Homeland Security - Examining the Current Status of Iran’s Axis of Resistance and the Implications for Homeland Security and U.S. Interests
April 30, 2024 - Statement of William F. Kimbell Chief of Operations Drug Enforcement Administration - Hearing Entitled, “TBD”
May 7, 2024 - Statement of Administrator Anne Milgram - Fiscal Year 2025 Request for the Drug Enforcement Administration